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Absrtract
Hepatocellular carcinoma (HCC) is an aggressive malignant tumor that occurs throughout the world. Μetastases
from hepatocellular carcinoma (HCC) were generally considered to be rare in the past, because the carcinoma had
an aggressive clinical course. In our era, has been reported that extra-hepatic metastases occur in 13.5%-41.7% of
HCC patients and this is considered as terminal-stage cancer. The prognosis for patients at this stage continues to
be poor due to limited effective treatment. The common sites of extrahepatic metastases in patients with HCC are
the lungs, regional lymph nodes, kidney, bone marrow and adrenals. We present here an extremely infrequent
case of a patient, without known liver disease, in which the presenting symptom was a pathological-in retrospect-
fracture of his right clavicle which wasn’t properly evaluated, until he presented a bulky mass in the region 6
months later. For our patient, the added diagnostic difficulty alongside the unknown liver disease, has been that
the clavicular metastases was the first presentation of any metastatic disease, rather than the more common sites
of HCC spread to adjacent lung or lymph nodes.
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Background
We present here a case of a patient, without known liver
disease, in which the presenting symptom was a fracture
of his right clavicle which wasn’t properly evaluated,
until he presented a bulky mass in the region 6 months
later. With the help of imaging techniques, tumor mar-
kers and immunohistochemistry, we were able to iden-
tify the primary site, a tumor in segment IV of the liver
and refer the patient for the proper treatment.
Bone metastasis of HCC is rare and usually located in
the spine, the pelvic bones and the ribs. A solitary bone
metastasis and a pathological fracture in the upper limb,
as presenting symptoms of HCC are extremely rare,
with only a few references in the literature.
Case presentation
A 67-year-old male, with history of a fracture of the med-
ial to inner third of his right clavicle 6 months ago, pre-
sented with an impressively bulky tumor in the right
clavicle region (Figure 1). From his medical history, a
visit in a regional hospital 6 months ago was referred,
due to constant pain in his right clavicle. The diagnosis
set at that time was a clavicle fracture due to physical
activity (farming). He was discharged from the hospital
being given conservative treatment. In our hospital, he
was subjected as an external patient to an ultrasound of
the aforementioned tumor which showed that it was
solid and in routine blood tests, which revealed a mild
anemia (Hct: 38%, Hb: 12,6 mg/dl) and a normal platelet
count (281 K/μlw i t hn o r m a lr a n g e1 4 0 - 4 4 0K / μl). We
then performed an open biopsy in the Operating Room
under local anesthesia in order to identify the type and
origin of the mass. Early histopathology exam was posi-
tive for malignancy but unable to provide accurate infor-
mation about the tumor, so the patient was admitted in
our hospital for further examination. Blood biochemical
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U/L, ALT = 94 U/L with normal ranges 5-40 U/L), while
the patient’s prothrombin time was within normal range
(PT = 11,4, INR = 1,01 with normal ranges 10,6-12,6 and
0,85-1,15 respectively). A thoracic CT and MRI followed
which revealed that the tumor was surrounding and
invading the right clavicle, while smaller lesions with the
same characteristics were present at the acromioclavicu-
lar junction. A Tc 99 m bone scan showed increased
deposition of the drug and disordered bone structure in
the right clavicle without any involvement of other bone
structures (Figure 2). A colonoscopy and esophagogastro-
duodenoscopy were performed and the latter revealed a
laceration of the larynx near the vocal cords and a possi-
ble subglottic mass. The patient was subjected to a biopsy
o ft h ea r e ai nq u e s t i o nw h i c hp r o v e dn e g a t i v ef o ra n y
malignancy, drawing our attention away from the neck.
Furthermore, he was subjected to an abdominal CT and
MRI scan which showed a mass in the segment IV of the
liver, with a characteristic contrast solution uptake in the
arterial phase possibly representing an HCC (Figure 3).
At that time, the histopathological findings and immuno-
histochemistry were available (see section below) which
revealed findings of metastatic HCC and made us con-
centrate even more on the liver. A sonovue enhanced
ultrasound was performed which confirmed our original
findings, a 5,7 cm area in segment IV with both central
and peripheral uptake on the arterial phase, which infil-
trated a branch of the middle hepatic vein, and which
was associated with two lesions in proximity that possibly
represented regenerative lesions. The patient’s blood tests
measured by ELISA (MEIA) came positive for HCV,
while his tumors markers showed elevated a-FP levels of
18,1 (normal values < 10). As a last exam, we decided to
perform an MRA of the aortic arch which showed that
the tumor was in close relation with the junction of the
right subclavian vein with the right jugular vein, without
clear marks of infiltration (Figure 4). The patient was
diagnosed with metastatic HCC, due to cirrhosis after
HCV infection and was referred to an oncologist in order
to receive systemic chemotherapy (cisplatin and epirubi-
cin, along with sorafenib) and local radiotherapy. At that
time we characterized, in retrospect, the fracture as
“pathological”, since the patient never actually mentioned
a specific high-energy injury in the clavicle area and the
diagnosis previous set was based in the absence of addi-
tional evidence.
Histopathological findings and
immunohistochemistry
Grossly, the surgical specimen from the clavicle tumor
consists of multiple, gray-white tissue parts of a total
volume of 20 cc.
Histologic examination of the specimen revealed a
neoplasm consisting of cells with eosinophilic cytoplasm,
enlarged hyperchromatic nuclei and prominent nucleoli.
The pattern of growth is mostly trabecular and the
Figure 1 Patient photo. Patient photo showing the external bulky
right clavicle mass.
Figure 2 MRI and Tc 99 m bone scan. MRI and Tc 99 m bone scan revealing tumor location and relation with the right clavicle.
Mantonakis et al. World Journal of Surgical Oncology 2012, 10:50
http://www.wjso.com/content/10/1/50
Page 2 of 5stroma is composed of sinusoid-like blood spaces with
varying degrees of dilatation, lined by a single layer of
endothelial cells (Figure 5).
Immunohistochemically, the neoplastic cells show
positive staining for Hep-Par-1 (Figure 6), cytokeratin 8/
18, CD10 and negative staining for cytokeratin 7, 19, 20,
aFP, Ber-EP4, TTF-1, thyroglobulin, vimentin, chromo-
granin and synaptophysin. According to these, the
tumor is classified as a malignant epithelial neoplasm
with hepatocellular differentiation, most probably deriv-
ing from the liver.
Discussion
HCC is a malignant tumor derived from hepatocytes.
Viral infections (HBV, HCV) and chronic alcohol abuse
are the most common etiological factors. Liver cirrhosis
is the major clinical HCC risk factor. HCCs, in a per-
centage of 70-90% develop on the background of macro-
nodular cirrhosis, while males are always more
frequently affected than females. A recent cohort study
has shown an increase in the number of individuals
with HCV in the last decade (from 17,261 in 1996 to
106,242 in 2006). Similarly, the prevalence of cirrhosis
increased from 9% to 18.5%, whereas the prevalence of
HCC increased approximately 20-fold (0.07% in 1996 to
1.3% in 2006) [1].
The presenting symptoms in patients with HCC
include abdominal pain, general malaise, anorexia or
weight loss and nausea or vomiting [2]. The majority of
patients with extrahepatic metastases experience no
Figure 4 MRA of the aortic arch. MRA of the aortic arch showing
the relation of the tumor with the junction of the right subclavian
vein and the right jugular vein.
Figure 5 Hematoxylin and Eosin staining. Hematoxylin and Eosin
staining revealing a neoplasm consisting of cells with eosinophilic
cytoplasm, enlarged hyperchromatic nuclei and prominent nucleoli,
mostly trabecular pattern of growth and stroma composed of
sinusoid-like blood spaces with varying degrees of dilatation, lined
by a single layer of endothelial cells.
Figure 6 Immunochemistry. Immunochemistry with Hep-Par-1
positive staining of the neoplastic cells.
Figure 3 Abdominal MRI scan. Abdominal MRI scan showing the
tumor at segment IV of the liver.
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hepatic metastases upon examination. Therefore,
increased detection of extrahepatic metastases suitable
for aggressive treatment may provide great benefit to
patients and improve overall survival of those with
HCC. HCC metastasis frequently occurs through the
intrahepatic blood vessels, lymphatic system or via direct
infiltration of the tumor. It has been reported that extra-
hepatic metastases occur in 13.5%-41.7% of HCC
patients which are mostly haematogenous, with the
lungs being the most common target, followed by
lymph nodes, adrenal glands and bones, especially in
skull [3-8]. Hematogenous metastases occur with the
involvement of the hepatic or portal veins or the vena
cava. The prognosis of patients with HCC is generally
very poor. Most studies report a five-year survival rate
of less than 5% in symptomatic HCC patients. HCCs are
largely resistant to radio- and chemotherapy. Advanced
intrahepatic lesions, presence of vascular tumour inva-
sion, elevated tumour markers and presence of viral
hepatitis are risk factors for extrahepatic metastasis [9].
Bony metastases of HCC are considered as one of the
most frequent extrahepatic metastases sites and occur as
multiple metastases in most patients [10]. In a recent
study, the outcome of HCC patients with bony metas-
tases was poor [11], which is similar to previous reports
[12,13]. Patients with metastases to bone had a median
survival of 6.7 months and usually located in the spine,
the pelvic bones and the ribs, while localization in the
upper and lower limbs is considered rare [14]. In a ser-
ies of 4953 patients analyzed by Seung Up Kim et al[15]
only 37 patients had bone metastasis and only one of
them had a clavicle and sternum metastasis at the same
time, while there is only a handful of reports with clavi-
cle involvement in the literature and none as it being
t h ef i r s ta n ds o l es y m p t o m .O u rp a t i e n tp r i o rt oh i s
admission was asymptomatic and without known liver
disease. The pathological fracture of his right clavicle
and the metastatic lesion which manifested right after it
were the presenting symptoms. He presented with an
impressive solitary tumor in the right clavicle, with
rapid growth and an unusual prolonged patient survival
which is noteworthy. We need to take into account that
he had a pathological fracture 6 months prior to his
admission (his liver disease must have been present long
before) and that he is still in good condition 1 year after
his admission, with the help of systemic chemotherapy
and local radiotherapy. There have been reports of soli-
tary bone metastases as presenting symptoms of HCC,
in example in the thoracic wall or in the skull, but they
are extremely rare and can be found only as case reports
[16-18]. It has also been suggested [19] that HCC cases
which present with “bone-only” metastasis have better
prognosis after hepatectomy and radiotherapy to the
bone lesion.
In the diagnosis of the present metastatic tumor, the
immunohistochemical marker of Hep-Par-1 was of con-
siderable diagnostic value. Hep-Par-1 is a monoclonal
antibody that reacts to an, as yet, unidentified cytoplas-
mic marker of normal and neoplastic hepatocytes. It
may also stain hepatoid adenocarcinomas (HAC) of the
gastrointestinal tract [20] which mainly arise in the sto-
mach and sporadically in the esophagus, papilla of
Vater, pancreas, gallbladder, large bowel, as well as in
several non-gastrointestinal sites, including lung and
urinary bladder. Hep-Par-1 may rarely also stain adrenal
gland carcinomas and other biliary tract and gastric car-
cinomas [21]. On a morphologic basis, yolk sac tumors
of testis also may display hepatoid phenotype.
As HAC and hepatocellular carcinoma (HCC) cannot
be differentiated on the basis of morphology alone, dif-
ferences in immunohistochemical reaction patterns
w o u l db eo fc o n s i d e r a b l ed i a g n o s t i ch e l p .H C C su s u a l l y
stain positively for CK8, CK18 and polyclonal CEA (the
latter with a canalicular staining pattern) and are usually
negative for Ber-EP4, CK7, CK19 and CK20, as it hap-
pens in our case. On the other hand, distinctive features
of both primary and metastatic HACs are positive stain-
ing for CK19 and CK20. Positivity of virtually all HACs
for aFP, CK8, CK18 and the membranous canalicular
staining for polyclonal CEA [22], underline their hepa-
toid nature. In contrast to the above immunophenotype,
in our case, CK19, CK20 and aFP are negative.
G a s t r i ca sw e l la sg a l l b l a d d e rc a r c i n o m a sw h i c hm a y
stain positive for Hep-Par-1, are usually also positive for
Ber-EP4 and CK7 in contrast to HCCs. The latter two
markers showed negative staining in our case. Adreno-
cortical carcinomas are usually positive for synaptophy-
sin and strongly positive for vimentin. Even
morphologically, these carcinomas do not show many
similarities to our case. Yolk sac tumor may display a
hepatoid phenotype only focally though, and in more
than half cases, positive staining for aFP is observed
[23].
Hepatocellular carcinoma is the tumor which corre-
sponds better to the discussed morphological and
immunohistochemical characters of our case. The cells
with eosinophilic cytoplasm, the trabecular pattern of
growth with sinusoid-like blood spaces lined by a single
layer of endothelial cells, as well as the positive canalicu-
lar staining for CD10, strongly suggest the diagnosis of a
metastatic HCC.
Our case comes as an addition to a few case reports in
the literature which describe solitary bone metastasis as
presenting symptoms of HCC, with the addition of a
pathological fracture which went unnoticed. In this
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be underlined. Each physician must be suspicious to this
kind of fractures, where mechanism of injury is not indi-
cative of such a fracture. The role of taking an inte-
grated medical history, seeking for malignant disease is
very important, because an unclear history can camou-
flage the actual cause of the fracture. These fractures
are not routinely suspected to be pathological, unless
being accompanied by obvious clinical or radiological
features of an underlying disease. This can result in a
considerable time lag between the first presentation of
the clavicular fracture and recognition that it is in fact
pathological [24]. Isolated bone metastasis from HCC
may not be as uncommon as previously believed. Clini-
cal doctors need to be on alert when evaluating patholo-
gical fractures and solitary bone metastasis for the
possibility of the liver being the primary site. When
biopsy sampling is possible, the use of modern imaging
techniques and immunochemistry markers like Hep-
Par-1 can prove invaluable in identifying the tumor
origin.
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